A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

A Cleveland Clinic study shows that semaglutide and tirzepatide—injectable GLP-1 drugs for obesity—produce smaller weight loss in a real-world setting because patients discontinue treatment or use ...

GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...

Early-stage study results suggest that a single shot of the company’s therapy, which works differently than GLP-1 medicines, ...

A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this ...

Eli Lilly is a global healthcare giant, generating strong growth from a diverse portfolio of blockbuster medications. Viking ...

Are you weening yourself off a compounded version of the drug? Considering switching insurers in order to keep your ...

Health experts are raising concerns for women using popular weight loss medications, particularly GLP-1s like Wegovy, ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...